Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy [3]

British Journal of Dermatology

Volumn 154, Issue 5, 2006, Pages 1000-1002

  Tillon, J ^a   Herve F ^a   Chevallier, D ^a   Muir, J F ^a   Levesque, H ^a   Marie, I ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; OMEPRAZOLE; VASODILATOR AGENT;

ADULT; ASPIRATION PNEUMONIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL ULCER; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; LETTER; LUNG INJURY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SARCOIDOSIS; SKIN ULCER; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

FEMALE; FINGERS; HUMANS; MIDDLE AGED; RECEPTORS, ENDOTHELIN; SARCOIDOSIS, PULMONARY; SCLERODERMA, SYSTEMIC; SKIN ULCER; SULFONAMIDES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645825875     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07194.x     Document Type: Letter

References (11)

1. Marie I Dominique S Levesque H et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001 45 346 54.
2. Cox D Conant E Earle L et al. Sarcoidosis in systemic sclerosis: report of 7 cases. J Rheumatol 1995 22 881 5.
3. De Bandt M Perrot S Masson C et al. Systemic sclerosis and sarcoidosis, a report of five cases. Br J Rheumatol 1997 36 117 9.
4. Humbert M Cabane J. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan. Rheumatology 2003 42 191 3.
5. Kawaguchi Y Suzuki K Hara M et al. Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis. Ann Rheum Dis 1994 53 506 10.
6. Ramos-Casals M Brito-Zeron P Nardi N et al. Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis. Rheumatology 2004 43 1454 6.
7. Sofia M Mormile M Faraone S et al. Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases. Sarcoidosis 1995 12 118 23.
8. Shahar I Fireman E Topilsky M et al. Effect of endothelin-1 on α-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases. Int J Immunopharmacol 1999 21 759 75.
9. Korn JH Mayes M Matucci Cerinic M et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004 50 3985 93.
10. Steen VD Medsger TA Jr.. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998 41 1613 9.
11. Selman M Thannickal VJ Pardo A et al. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004 64 405 30.